UBS Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.9M Sell
736,223
-320,627
-30% -$6.92M ﹤0.01% 2059
2025
Q1
$17.6M Sell
1,056,850
-184,425
-15% -$3.06M ﹤0.01% 1900
2024
Q4
$22.8M Buy
1,241,275
+637,123
+105% +$11.7M ﹤0.01% 1663
2024
Q3
$9.29M Buy
604,152
+148,601
+33% +$2.29M ﹤0.01% 1737
2024
Q2
$7.4M Buy
455,551
+111,670
+32% +$1.81M ﹤0.01% 1820
2024
Q1
$6.36M Buy
343,881
+36,522
+12% +$675K ﹤0.01% 1976
2023
Q4
$9.62M Buy
307,359
+162,663
+112% +$5.09M ﹤0.01% 1491
2023
Q3
$3.02M Buy
144,696
+4,995
+4% +$104K ﹤0.01% 2229
2023
Q2
$3.35M Sell
139,701
-13,490
-9% -$323K ﹤0.01% 2240
2023
Q1
$2.88M Sell
153,191
-214,128
-58% -$4.03M ﹤0.01% 2269
2022
Q4
$5.85M Buy
367,319
+316,246
+619% +$5.03M ﹤0.01% 1711
2022
Q3
$835K Buy
51,073
+17,271
+51% +$282K ﹤0.01% 2992
2022
Q2
$477K Sell
33,802
-29,631
-47% -$418K ﹤0.01% 3372
2022
Q1
$1.54M Sell
63,433
-155,475
-71% -$3.77M ﹤0.01% 2875
2021
Q4
$5.11M Buy
218,908
+1,405
+0.6% +$32.8K ﹤0.01% 2068
2021
Q3
$3.61M Buy
217,503
+205,648
+1,735% +$3.42M ﹤0.01% 2290
2021
Q2
$289K Sell
11,855
-15,080
-56% -$368K ﹤0.01% 4097
2021
Q1
$695K Sell
26,935
-11,726
-30% -$303K ﹤0.01% 3669
2020
Q4
$2.07M Buy
38,661
+8,283
+27% +$443K ﹤0.01% 2610
2020
Q3
$1.25M Buy
30,378
+5,951
+24% +$245K ﹤0.01% 2777
2020
Q2
$1.18M Buy
24,427
+422
+2% +$20.5K ﹤0.01% 2687
2020
Q1
$1.01M Sell
24,005
-115,667
-83% -$4.89M ﹤0.01% 2643
2019
Q4
$5.98M Buy
139,672
+20,250
+17% +$866K ﹤0.01% 1881
2019
Q3
$4.3M Buy
119,422
+60,565
+103% +$2.18M ﹤0.01% 1976
2019
Q2
$1.57M Sell
58,857
-20,150
-26% -$539K ﹤0.01% 2701
2019
Q1
$2.12M Sell
79,007
-226,807
-74% -$6.09M ﹤0.01% 2381
2018
Q4
$4.95M Sell
305,814
-3,860
-1% -$62.4K ﹤0.01% 1703
2018
Q3
$6.43M Buy
309,674
+131,931
+74% +$2.74M ﹤0.01% 1697
2018
Q2
$2.71M Sell
177,743
-261,344
-60% -$3.99M ﹤0.01% 2310
2018
Q1
$9.87M Buy
439,087
+221,465
+102% +$4.98M ﹤0.01% 1344
2017
Q4
$6.55M Sell
217,622
-35,213
-14% -$1.06M ﹤0.01% 1630
2017
Q3
$9.52M Buy
252,835
+7,955
+3% +$300K ﹤0.01% 1297
2017
Q2
$6.83M Buy
244,880
+165,503
+209% +$4.62M ﹤0.01% 1459
2017
Q1
$2.73M Sell
79,377
-104,105
-57% -$3.58M ﹤0.01% 2094
2016
Q4
$5.29M Buy
183,482
+25,472
+16% +$735K ﹤0.01% 1552
2016
Q3
$5.03M Sell
158,010
-29,577
-16% -$941K ﹤0.01% 1543
2016
Q2
$6.09M Buy
187,587
+170,485
+997% +$5.53M ﹤0.01% 1360
2016
Q1
$479K Buy
17,102
+4,158
+32% +$116K ﹤0.01% 3151
2015
Q4
$461K Sell
12,944
-40,084
-76% -$1.43M ﹤0.01% 3210
2015
Q3
$1.75M Buy
53,028
+35,413
+201% +$1.17M ﹤0.01% 2240
2015
Q2
$738K Buy
17,615
+2,511
+17% +$105K ﹤0.01% 2998
2015
Q1
$492K Sell
15,104
-23,617
-61% -$769K ﹤0.01% 3239
2014
Q4
$1.23M Buy
+38,721
New +$1.23M ﹤0.01% 2605